These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 18978469)
1. New approaches to treatment of primary immunodeficiencies: fixing mutations with chemicals. Hu H; Gatti RA Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):540-6. PubMed ID: 18978469 [TBL] [Abstract][Full Text] [Related]
2. Exon-skipping antisense oligonucleotides to correct missplicing in neurogenetic diseases. Siva K; Covello G; Denti MA Nucleic Acid Ther; 2014 Feb; 24(1):69-86. PubMed ID: 24506781 [TBL] [Abstract][Full Text] [Related]
3. Skipping multiple exons of dystrophin transcripts using cocktail antisense oligonucleotides. Echigoya Y; Yokota T Nucleic Acid Ther; 2014 Feb; 24(1):57-68. PubMed ID: 24380394 [TBL] [Abstract][Full Text] [Related]
4. Potential therapeutic applications of antisense morpholino oligonucleotides in modulation of splicing in primary immunodeficiency diseases. Du L; Gatti RA J Immunol Methods; 2011 Feb; 365(1-2):1-7. PubMed ID: 21147113 [TBL] [Abstract][Full Text] [Related]
5. New approaches to the treatment of orphan genetic disorders: Mitigating molecular pathologies using chemicals. Velho RV; Sperb-Ludwig F; Schwartz IV An Acad Bras Cienc; 2015 Aug; 87(2 Suppl):1375-88. PubMed ID: 26247150 [TBL] [Abstract][Full Text] [Related]
12. Correction of prototypic ATM splicing mutations and aberrant ATM function with antisense morpholino oligonucleotides. Du L; Pollard JM; Gatti RA Proc Natl Acad Sci U S A; 2007 Apr; 104(14):6007-12. PubMed ID: 17389389 [TBL] [Abstract][Full Text] [Related]
13. Splicing in the immune system: potential targets for therapeutic intervention by antisense-mediated alternative splicing. Mourich DV; Iversen PL Curr Opin Mol Ther; 2009 Apr; 11(2):124-32. PubMed ID: 19330718 [TBL] [Abstract][Full Text] [Related]
14. An update on gain-of-function mutations in primary immunodeficiency diseases. Jhamnani RD; Rosenzweig SD Curr Opin Allergy Clin Immunol; 2017 Dec; 17(6):391-397. PubMed ID: 29040208 [TBL] [Abstract][Full Text] [Related]
15. Modern management of primary T-cell immunodeficiencies. Pachlopnik Schmid J; Güngör T; Seger R Pediatr Allergy Immunol; 2014 Jun; 25(4):300-13. PubMed ID: 24383740 [TBL] [Abstract][Full Text] [Related]